CIK 0001770121
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831381173
- Phone
- +1 206-701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-08 | CRANDELL KEITH 10% owner | Purchase | +363,637 | $5.50 | $2.0M | 10,667,387 |
| 2024-02-08 | CRANDELL KEITH 10% owner | Purchase | +727,272 | $5.50 | $4.0M | 12,446,022 |
| 2024-02-08 | CRANDELL KEITH 10% owner | Purchase | +727,272 | $5.50 | $4.0M | 12,446,022 |
Page 1 of 1 · 3 trades